AMN Healthcare Reports Financials and Agreements
Ticker: AMN · Form: 8-K · Filed: Nov 7, 2024 · CIK: 1142750
| Field | Detail |
|---|---|
| Company | Amn Healthcare Services Inc (AMN) |
| Form Type | 8-K |
| Filed Date | Nov 7, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, financial-condition, financial-obligation
TL;DR
AMN Healthcare filed an 8-K detailing financial results and a new material agreement, potentially impacting its financial obligations.
AI Summary
On November 5, 2024, AMN Healthcare Services, Inc. entered into a material definitive agreement related to its financial obligations. The company also reported its results of operations and financial condition. Specific details regarding the agreement and financial results were not fully disclosed in the provided text, but the filing indicates a direct financial obligation or an off-balance sheet arrangement.
Why It Matters
This filing provides insight into AMN Healthcare's financial health and any new material agreements, which could impact its future operations and investor outlook.
Risk Assessment
Risk Level: medium — The filing involves material definitive agreements and financial condition, which inherently carry medium risk due to potential impacts on the company's financial obligations and performance.
Key Players & Entities
- AMN HEALTHCARE SERVICES, INC. (company) — Registrant
- November 5, 2024 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 2999 Olympus Boulevard, Suite 500 Dallas, Texas 75019 (address) — Principal executive offices
FAQ
What is the nature of the material definitive agreement entered into by AMN Healthcare Services, Inc. on November 5, 2024?
The filing indicates the entry into a material definitive agreement related to a direct financial obligation or an off-balance sheet arrangement, but specific terms are not detailed in the provided text.
What specific financial results are reported in this 8-K filing?
The filing states that it includes 'Results of Operations and Financial Condition,' but the specific financial figures are not present in the provided excerpt.
What is the exact date of the earliest event reported in this filing?
The earliest event reported is dated November 5, 2024.
Where are AMN Healthcare Services, Inc.'s principal executive offices located?
The principal executive offices are located at 2999 Olympus Boulevard, Suite 500, Dallas, Texas 75019.
What is the Commission File Number for AMN Healthcare Services, Inc.?
The Commission File Number for AMN Healthcare Services, Inc. is 001-16753.
Filing Stats: 736 words · 3 min read · ~2 pages · Grade level 10.1 · Accepted 2024-11-07 16:16:16
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share AMN NYSE Indicate by ch
Filing Documents
- eh240554258_8k.htm (8-K) — 28KB
- eh240554258_ex9901.htm (EX-99.1) — 196KB
- 0000950142-24-002692.txt ( ) — 418KB
- amn-20241105.xsd (EX-101.SCH) — 3KB
- amn-20241105_lab.xml (EX-101.LAB) — 33KB
- amn-20241105_pre.xml (EX-101.PRE) — 22KB
- eh240554258_8k_htm.xml (XML) — 4KB
01
Item 1.01. Entry into a Material Definitive Agreement. On November 5, 2024, AMN Healthcare Services, Inc. (the "Company") and AMN Healthcare, Inc., a wholly owned subsidiary of the Company (the "Borrower"), entered into a Fourth Amendment (the "Fourth Amendment") to the existing Credit Agreement (as amended, the "Credit Agreement"), dated as of February 9, 2018, by and among the Company, the Borrower, certain subsidiaries of the Company as guarantors, the several lenders party thereto from time to time (the "Lenders") and Truist Bank, as administrative agent. Pursuant to the Fourth Amendment, the maximum Consolidated Net Leverage Ratio (as defined in and calculated in accordance with the Credit Agreement) was increased to 4.50 to 1.00 for the period commencing on December 31, 2024 to and including December 31, 2025. Following December 31, 2025, the maximum Consolidated Net Leverage Ratio will revert to 4.00 to 1.00. The foregoing summary of the Fourth Amendment is qualified in its entirety by reference to the full text of the Fourth Amendment, a copy of which will be filed as an exhibit to the Company's next Quarterly Report on Form 10-Q, and which is incorporated by reference herein.
02
Item 2.02. Results of Operations and Financial Condition. On November 7, 2024, the Company reported its results for the fiscal quarter ended September 30, 2024. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated by reference herein. The information in this Item 2.02, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent as shall be expressly set forth by specific reference in such filing.
03
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information contained in Item 1.01 above is hereby incorporated in this Item 2.03 by reference.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued on November 7, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMN Healthcare Services, Inc. Date: November 7, 2024 By: /s/ Cary Grace Name: Cary Grace Title: Chief Executive Officer